Endpoints News Dec 15, 2025 Areteia Therapeutics to wind down after terminating Phase 3 asthma studies
Endpoints News Dec 15, 2025 Immunome's rare tumor drug passes Phase 3 test, could challenge Merck KGaA
Thermo Fisher Dec 15, 2025 Thermo Fisher Expands Gibco Bacto CD Portfolio with New E. coli Media - Contract Pharma
Illumina Dec 15, 2025 Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Endpoints News Dec 15, 2025 Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfront
Thermo Fisher Dec 15, 2025 Wells Fargo Adjusts PT on Thermo Fisher Scientific to $675 From $635, Maintains Overweight Rating - marketscreener.com
10x Genomics Blog Dec 15, 2025 BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $18 - 富途牛牛
PLoS Biology Dec 15, 2025 USPPAR is a cost-effective, scalable, and highly sensitive single-cell RNA sequencing workflow compatible with diverse specimens
PLoS Biology Dec 15, 2025 Bacterial gene 5′ ends have unusual mutation rates that can mislead tests of selection
Thermo Fisher Dec 15, 2025 Neville Rodie & Shaw Inc. Cuts Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
BioPharma Dive Dec 15, 2025 Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease
BioWorld Dec 15, 2025 Minova Pharmaceutical and Precision Brain Science describe new salts of deuterated dextromethorphan